Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: While I don't usually like to speculate

Oct 13, 2006 03:23PM

Oct 13, 2006 03:26PM

Oct 13, 2006 04:19PM

Oct 13, 2006 04:38PM
I find it interesting that the note regarding the $33 million in the 1st quarter was worded "received proceeds" as opposed to "with licensing revenues totalling". They announced the Fujitsu deal on March 2. On April 5 they announced that PTSC received the proceeds from the Fujitsu deal. Assuming that PDS doesn't hold onto the money at all (no reason they should) it's safe to assume that Fujitsu actually paid around April 5. It's conceivable (not probable or likely or anything like that) that our revenues may be higher than disucssed in the 1st quarter considering the Olympus and Kenwwod deals were announced in September and the proceeds from those deals may not have been received by PDS by October 3. I found it odd that they chose October 3 as the cutoff time to report thru. October 11 (the date of the Audit Report) or even September 30 would have made more sense. Why October 3. Bushleague, what do you think????

Oct 13, 2006 05:53PM
Share
New Message
Please login to post a reply